Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 16, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print June 16, 2005, doi: 10.1161/01.ATV.0000174125.89058.b6
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/8/1684    most recent
01.ATV.0000174125.89058.b6v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choy, K.
Right arrow Articles by Stocker, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choy, K.
Right arrow Articles by Stocker, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Related Collections
Right arrow Pathophysiology
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors

Submitted on January 11, 2005
Accepted on June 3, 2005

Processes Involved in the Site-Specific Effect of Probucol on Atherosclerosis in Apolipoprotein E Gene Knockout Mice

Katherine Choy ; Konstanze Beck ; Francoise Y. Png ; Ben J. Wu ; Steven B. Leichtweis ; Shane R. Thomas ; Jing Y. Hou ; Kevin D. Croft ; Trevor A. Mori ; and Roland Stocker *

From Centre for Vascular Research (K.C., K.B., F.Y.P., B.J.W., S.R.T., R.S.), University of New South Wales, Sydney, Australia; Heart Research Institute (S.B.L., J.Y.H.), Sydney, Australia; University of Western Australia (K.D.C., T.A.M.), School of Medicine and Pharmacology, Perth, Western Australia, Australia.

* To whom correspondence should be addressed. E-mail: r.stocker{at}unsw.edu.au.

Objective--To elucidate processes by which the antioxidant probucol increases lesion size at the aortic sinus and decreases atherosclerosis at more distal sites in apolipoprotein E-deficient (apoE-/-) mice.

Methods and Results--Male apoE-/- mice were fed high-fat chow with 1% (w/w) probucol or without (controls) for 6 months, before aortic sinus, arch, and descending aorta were analyzed separately for lesion size and composition. Compared with control, probucol significantly increased lesion size by 33% at the sinus, but it inhibited atherosclerosis at the descending aorta by 94%. Sites where atherosclerosis was inhibited contained substantially fewer macrophages, less lipids (cholesterol and cholesteryl esters), and endogenous antioxidant ({alpha}-tocopherol), but not oxidized lipids, and the extent to which probucol metabolism occurred was increased. Compared with control, aortic sinus lesions of probucol mice contained a substantially increased content of extracellular matrix, but decreased total cell and macrophage density, comparable levels of lipids and {alpha}-tocopherol, and decreased concentrations of oxidized lipids (cholesteryl ester hydroperoxides, F2-isoprostanes, and 7-ketocholesterol).

Conclusions--Probucol affects atherosclerosis in apoE-/- mice independent of the accumulation of arterial lipid oxidation products, thereby dissociating the 2 processes. Rather, probucol exerts antiinflammatory activity by decreasing accumulation of macrophages in lesions, and it promotes a more stable lesion composition at the aortic sinus.


Key words: antioxidants • atherosclerosis • collagen • free radicals • inflammation




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. A. Goodman, D. Horvath, C. Stathis, T. Mori, K. Croft, R. M. Murphy, and A. Hayes
Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation
J Appl Physiol, July 1, 2009; 107(1): 144 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Wu, N. Di Girolamo, K. Beck, C. G. Hanratty, K. Choy, J. Y. Hou, M. R. Ward, and R. Stocker
Probucol [4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. J. Wu, K. Kathir, P. K. Witting, K. Beck, K. Choy, C. Li, K. D. Croft, T. A. Mori, D. Tanous, M. R. Adams, et al.
Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging
J. Exp. Med., April 17, 2006; 203(4): 1117 - 1127.
[Abstract] [Full Text] [PDF]